Cargando…

TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line

Chronic obstructive pulmonary disease (COPD) is considered as the strongest independent risk factor for lung cancer (LC) development, suggesting an overlapping genetic background in both diseases. A common feature of both diseases is aberrant immunity in respiratory epithelia that is mainly regulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Baranašić, Jurica, Šutić, Maja, Catalano, Calogerina, Drpa, Gordana, Huhn, Stefanie, Majhen, Dragomira, Nestić, Davor, Kurtović, Matea, Rumora, Lada, Bosnar, Martina, Vukić Dugac, Andrea, Sokolović, Irena, Popovic-Grle, Sanja, Oršolić, Nada, Škrinjarić-Cincar, Sanda, Jakopović, Marko, Samaržija, Miroslav, Weber, Alexander N. R., Försti, Asta, Knežević, Jelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496592/
https://www.ncbi.nlm.nih.gov/pubmed/36140341
http://dx.doi.org/10.3390/biomedicines10092240
_version_ 1784794307432022016
author Baranašić, Jurica
Šutić, Maja
Catalano, Calogerina
Drpa, Gordana
Huhn, Stefanie
Majhen, Dragomira
Nestić, Davor
Kurtović, Matea
Rumora, Lada
Bosnar, Martina
Vukić Dugac, Andrea
Sokolović, Irena
Popovic-Grle, Sanja
Oršolić, Nada
Škrinjarić-Cincar, Sanda
Jakopović, Marko
Samaržija, Miroslav
Weber, Alexander N. R.
Försti, Asta
Knežević, Jelena
author_facet Baranašić, Jurica
Šutić, Maja
Catalano, Calogerina
Drpa, Gordana
Huhn, Stefanie
Majhen, Dragomira
Nestić, Davor
Kurtović, Matea
Rumora, Lada
Bosnar, Martina
Vukić Dugac, Andrea
Sokolović, Irena
Popovic-Grle, Sanja
Oršolić, Nada
Škrinjarić-Cincar, Sanda
Jakopović, Marko
Samaržija, Miroslav
Weber, Alexander N. R.
Försti, Asta
Knežević, Jelena
author_sort Baranašić, Jurica
collection PubMed
description Chronic obstructive pulmonary disease (COPD) is considered as the strongest independent risk factor for lung cancer (LC) development, suggesting an overlapping genetic background in both diseases. A common feature of both diseases is aberrant immunity in respiratory epithelia that is mainly regulated by Toll-like receptors (TLRs), key regulators of innate immunity. The function of the flagellin-sensing TLR5 in airway epithelia and pathophysiology of COPD and LC has remained elusive. We performed case–control genetic association and functional studies on the importance of TLR5 in COPD and LC development, comparing Caucasian COPD/LC patients (n = 974) and healthy donors (n = 1283). Association analysis of three single nucleotide polymorphisms (SNPs) (rs725084, rs2072493_N592S, and rs5744174_F616L) indicated the minor allele of rs2072493_N592S to be associated with increased risk for COPD (OR = 4.41, p < 0.0001) and NSCLC (OR = 5.17, p < 0.0001) development and non-small cell LC risk in the presence of COPD (OR = 1.75, p = 0.0031). The presence of minor alleles (rs5744174 and rs725084) in a co-dominant model was associated with overall survival in squamous cell LC patients. Functional analysis indicated that overexpression of the rs2072493_N592S allele affected the activation of NF-κB and AP-1, which could be attributed to impaired phosphorylation of p38 and ERK. Overexpression of TLR5(N592S) was associated with increased chemosensitivity in the H1299 cell line. Finally, genome-wide transcriptomic analysis on WI-38 and H1299 cells overexpressing TLR5(WT) or TLR5(N592S), respectively, indicated the existence of different transcription profiles affecting several cellular pathways potentially associated with a dysregulated immune response. Our results suggest that TLR5 could be recognized as a potential biomarker for COPD and LC development with functional relevance.
format Online
Article
Text
id pubmed-9496592
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94965922022-09-23 TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line Baranašić, Jurica Šutić, Maja Catalano, Calogerina Drpa, Gordana Huhn, Stefanie Majhen, Dragomira Nestić, Davor Kurtović, Matea Rumora, Lada Bosnar, Martina Vukić Dugac, Andrea Sokolović, Irena Popovic-Grle, Sanja Oršolić, Nada Škrinjarić-Cincar, Sanda Jakopović, Marko Samaržija, Miroslav Weber, Alexander N. R. Försti, Asta Knežević, Jelena Biomedicines Article Chronic obstructive pulmonary disease (COPD) is considered as the strongest independent risk factor for lung cancer (LC) development, suggesting an overlapping genetic background in both diseases. A common feature of both diseases is aberrant immunity in respiratory epithelia that is mainly regulated by Toll-like receptors (TLRs), key regulators of innate immunity. The function of the flagellin-sensing TLR5 in airway epithelia and pathophysiology of COPD and LC has remained elusive. We performed case–control genetic association and functional studies on the importance of TLR5 in COPD and LC development, comparing Caucasian COPD/LC patients (n = 974) and healthy donors (n = 1283). Association analysis of three single nucleotide polymorphisms (SNPs) (rs725084, rs2072493_N592S, and rs5744174_F616L) indicated the minor allele of rs2072493_N592S to be associated with increased risk for COPD (OR = 4.41, p < 0.0001) and NSCLC (OR = 5.17, p < 0.0001) development and non-small cell LC risk in the presence of COPD (OR = 1.75, p = 0.0031). The presence of minor alleles (rs5744174 and rs725084) in a co-dominant model was associated with overall survival in squamous cell LC patients. Functional analysis indicated that overexpression of the rs2072493_N592S allele affected the activation of NF-κB and AP-1, which could be attributed to impaired phosphorylation of p38 and ERK. Overexpression of TLR5(N592S) was associated with increased chemosensitivity in the H1299 cell line. Finally, genome-wide transcriptomic analysis on WI-38 and H1299 cells overexpressing TLR5(WT) or TLR5(N592S), respectively, indicated the existence of different transcription profiles affecting several cellular pathways potentially associated with a dysregulated immune response. Our results suggest that TLR5 could be recognized as a potential biomarker for COPD and LC development with functional relevance. MDPI 2022-09-09 /pmc/articles/PMC9496592/ /pubmed/36140341 http://dx.doi.org/10.3390/biomedicines10092240 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Baranašić, Jurica
Šutić, Maja
Catalano, Calogerina
Drpa, Gordana
Huhn, Stefanie
Majhen, Dragomira
Nestić, Davor
Kurtović, Matea
Rumora, Lada
Bosnar, Martina
Vukić Dugac, Andrea
Sokolović, Irena
Popovic-Grle, Sanja
Oršolić, Nada
Škrinjarić-Cincar, Sanda
Jakopović, Marko
Samaržija, Miroslav
Weber, Alexander N. R.
Försti, Asta
Knežević, Jelena
TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
title TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
title_full TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
title_fullStr TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
title_full_unstemmed TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
title_short TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
title_sort tlr5 variants are associated with the risk for copd and nsclc development, better overall survival of the nsclc patients and increased chemosensitivity in the h1299 cell line
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496592/
https://www.ncbi.nlm.nih.gov/pubmed/36140341
http://dx.doi.org/10.3390/biomedicines10092240
work_keys_str_mv AT baranasicjurica tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT suticmaja tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT catalanocalogerina tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT drpagordana tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT huhnstefanie tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT majhendragomira tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT nesticdavor tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT kurtovicmatea tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT rumoralada tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT bosnarmartina tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT vukicdugacandrea tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT sokolovicirena tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT popovicgrlesanja tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT orsolicnada tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT skrinjariccincarsanda tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT jakopovicmarko tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT samarzijamiroslav tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT weberalexandernr tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT forstiasta tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline
AT knezevicjelena tlr5variantsareassociatedwiththeriskforcopdandnsclcdevelopmentbetteroverallsurvivalofthensclcpatientsandincreasedchemosensitivityintheh1299cellline